Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IL8-H5217 | Human | Human IL-8 / CXCL8 Protein, premium grade |  |
|
|
| CRS-B004 | Human | ClinMax™ Human IL-8 ELISA Kit | |||
| IL8-C52H4 | Rhesus macaque | Rhesus macaque IL-8 / CXCL8 Protein, His Tag (MALS verified) |  |
|
|
| CEA-C004 | Human | ClinMax™ Human IL-8 ELISA Kit, PRO | |||
| IL8-H82H3 | Human | Biotinylated Human IL-8 protein, His,Avitag™ |  |
|
|
| IL8-H5258 | Human | Human IL-8 / CXCL8 Protein, Fc Tag |  |
|
|
| IL8-H52H3 | Human | Human IL-8 / CXCL8 Protein, His Tag |  |
|
|
Immobilized Rhesus macaque IL-8 / CXCL8 Protein, His Tag (Cat. No. IL8-C52H4) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human IL-8 Antibody, Human IgG1 with a linear range of 0.1-3 ng/mL (QC tested).
The purity of Rhesus macaque IL-8 Protein, His Tag (Cat. No. IL8-C52H4) is more than 85% and the molecular weight of this protein is around 14-20 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Mouse monoclonal antibody against human interleukin-8 cream | Approved | Dalian Asia Space Pharmaceutical Co Ltd, Dongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd | 恩博克 | Mainland China | Eczema; Psoriasis | Dalian Asia Space Pharmaceutical Co Ltd | 2001-04-10 | Psoriasis; Eczema | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Tissue Adhesions; Post-surgical adhesions; Cicatrix | Details |
| Sodium Hypochlorite | Phase 3 Clinical | Cystic Fibrosis; Pulpitis; Infections; Pain; Pain, Postoperative; Fibrosis; Dental Pulp Necrosis | Details | ||
| Adakitug | BMS-986253; MDX-018 | Phase 2 Clinical | Medarex Inc, Genmab A/S, Bristol-Myers Squibb Company | Hematologic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Myelodysplastic Syndromes; Coronavirus Disease 2019 (COVID-19); Neoplasms; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Melanoma | Details |
| AMY-109 | AMY-109; AMY109 | Phase 2 Clinical | Chugai Pharmaceutical Co Ltd | Solid tumours; Endometriosis | Details |
| AC-701 | AC-701 | Phase 2 Clinical | Twi Pharmaceuticals Inc | Rosacea; Exanthema | Details |
This web search service is supported by Google Inc.
A-Z
